Hans‐Georg Buchholz

Author

Hans‐Georg Buchholz

Johannes Gutenberg University Mainz

Also Known As

Hans-Georg Buchholz, Hans‐Georg Buchholz

Publications

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz RWTH Aachen University Ludwig-Maximilians-Universität München Aarhus University Hospital University of Applied Sciences Mainz

About

Hans‐Georg Buchholz is an author at Johannes Gutenberg University Mainz specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	692
2	Neuroscience	6	6	420
3	Social Sciences	5	5	302
4	Neurology	3	3	172
5	Health Sciences	1	1	118

Hans‐Georg Buchholz

Publications

Citations

H-Index

Page 1

	Year	Citations
Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide Gregor J. Förster, M. Engelbach, Jörg Brockmann, European Journal of Nuclear Medicine and Molecular Imaging MedicinePharmacologyRadiopharmaceutical TherapyPharmacotherapyTherapy Planning	2001	143
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours Andreas Helisch, GregorJ. F�rster, Helmut Reber, European Journal of Nuclear Medicine and Molecular Imaging GliomaMedicinePharmacologyNeuroendocrine DisorderCancer Treatment	2004	129
Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18 Igor Yakushev, Christian Landvogt, Hans‐Georg Buchholz, Psychiatry Research Neuroimaging Positron Emission TomographyReference AreaAlzheimer's DiseaseDementiaBiomedical Imaging	2008	118
Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo Gerhard Gründer, Ingo Vernaleken, Matthias J. Müller, Neuropsychopharmacology Schizophrenic PatientsNeuropsychologyPsychiatryPsychotic DisorderPsychotropic Medication	2002	107
Decreased Dopamine D2/D3‐Receptor Binding in Temporal Lobe Epilepsy: An [<sup>18</sup>F]Fallypride PET Study Konrad J. Werhahn, Christian Landvogt, Sven Klimpe, Epilepsia	2006	96
The Striatal and Extrastriatal D2/D3 Receptor-Binding Profile of Clozapine in Patients with Schizophrenia Gerhard Gründer, Christian Landvogt, Ingo Vernaleken, Neuropsychopharmacology PsychiatryPsychotic DisorderPsychotropic MedicationPsychopharmacologySchizophrenia	2005	95
Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy Christian Landvogt, Hans‐Georg Buchholz, Viviane Bernedo, Epilepsia	2010	69
‘Prefrontal’ cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: An exploratory [<sup>18</sup>F]‐fluoro‐L‐DOPA‐PET investigation Ingo Vernaleken, Hans‐Georg Buchholz, Yoshitaka Kumakura, Human Brain Mapping	2006	63
Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride. Gerhard Gründer, Thomas Siessmeier, Markus Piel, PubMed	2003	55
Striatal and Extrastriatal D2/D3-Receptor-Binding Properties of Ziprasidone Ingo Vernaleken, Christine Fellows, Hildegard Janouschek, Journal of Clinical Psychopharmacology NeuropsychologyHealthy SubjectsPsychopharmacologyPharmacotherapySocial Sciences	2008	46

Page 1